Can Dermatrophin PMG (Dermateopin PMG) be used for inflammatory hair loss, and what is the recommended dosage, duration, and monitoring?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dermatrophin PMG Cannot Be Recommended for Inflammatory Hair Loss

Dermatrophin PMG (also called Dermateopin PMG) is compressed medical air and has no therapeutic role in treating inflammatory hair loss. The FDA drug label 1 clearly identifies this product as compressed medical air (21% oxygen USP, 79% nitrogen NF) intended for breathing maintenance, not a pharmaceutical treatment for dermatologic conditions.

Why This Product Is Not Appropriate

The product you're asking about is literally compressed air in a cylinder - it contains no active pharmaceutical ingredients that could address inflammatory hair loss mechanisms. The label explicitly states it should only be administered "by adequately trained personnel experienced in the use and administration of compressed air" for breathing maintenance 1.

Evidence-Based Treatments for Inflammatory Hair Loss

Since you're seeking treatment for inflammatory hair loss, here are the actual evidence-based options depending on the specific condition:

For Alopecia Areata (Patchy Hair Loss)

Intralesional corticosteroids are the first-line treatment for limited patchy disease:

  • Use triamcinolone acetonide 5-10 mg/mL injected just beneath the dermis
  • Inject 0.05-0.1 mL per site (produces ~0.5 cm diameter tuft of regrowth)
  • Repeat monthly; 62% achieve full regrowth with this approach
  • Best for fewer than 5 patches under 3 cm diameter 2

For moderate-to-severe disease (≥21% scalp involvement):

  • JAK inhibitors (ritlecitinib for ages ≥12 years, baricitinib for adults ≥18 years) are now approved and highly effective 3, 4
  • Topical minoxidil can be added as adjuvant therapy in chronic cases 4

For Scarring Alopecias (Lichen Planopilaris, Frontal Fibrosing Alopecia, Folliculitis Decalvans)

Multimodal therapy is essential because hair loss is irreversible:

  • Start with oral dutasteride plus topical/intralesional corticosteroids
  • Add hydroxychloroquine if inflammation persists 5
  • Topical tacrolimus 0.1% solution shows 72.7% excellent response at 2 months for maintenance 6
  • For folliculitis decalvans: antibiotics first-line; isotretinoin for refractory cases 7

Critical Pitfall to Avoid

Do not waste time with unproven products like compressed air when effective FDA-approved treatments exist. Inflammatory hair loss, particularly scarring types, causes permanent follicle destruction - early aggressive treatment with proven therapies is essential to prevent irreversible hair loss 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.